Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artekin vs Standard Treatment for Malaria in Afghanistan
NCT00682578Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Jul 2007
- Primary completion
- Feb 2010
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dihydroartemisinin + piperaquine in Plasmodium falciparum malaria and malaria (2 arms), sponsored by University of Oxford. Primary endpoint: PCR corrected adequate clinical and parasitological response at Day 56. Started Jul 2007; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Plasmodium falciparum malariamalaria
Beyond the preview
Go deeper on NCT00682578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682578.